MedTrace Logo

Treatment of Depression in the Elderly

NCT00130455 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2007-02-06

No results posted yet for this study

Summary

The study is designed to establish the efficacy and tolerability of escitalopram in the treatment of depressive episodes of mild to moderate severity in the elderly.

The study is designed as a mainly naturalistic study including all patients of 65 years of age or above that judged by the clinician would benefit from treatment by an antidepressant medication. The study is designed as a double-blind, randomised placebo controlled study with two groups of active treatment (escitalopram in two doses, 5 or 10 mg daily) in a twelve week period.

Conditions

Interventions

DRUG

escitalopram

Sponsors & Collaborators

  • Psychogeriatric Unit, CU Hospital, Frederiksberg

    collaborator UNKNOWN

  • Amager Hospital

    collaborator OTHER

  • Psychiatric Center Ballerup

    collaborator OTHER

  • Geriatric Department,Korsør, Vestsjælland

    collaborator UNKNOWN

  • Psychiatric Hospital, Hillerod

    lead OTHER

Principal Investigators

  • Alex Koerner, MD · Psychiatric hospital, Hilleroed, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Completion
2008-01-31

Countries

  • Denmark

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00130455 on ClinicalTrials.gov